Annual EBITDA:
-$109.63M+$118.17M(+51.88%)Summary
- As of today, ARQT annual EBITDA is -$109.63 million, with the most recent change of +$118.17 million (+51.88%) on December 31, 2024.
- During the last 3 years, ARQT annual EBITDA has risen by +$96.28 million (+46.76%).
- ARQT annual EBITDA is now -2569.87% below its all-time high of -$4.11 million, reached on December 31, 2017.
Performance
ARQT EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBITDA:
-$14.05M+$7.35M(+34.35%)Summary
- As of today, ARQT quarterly EBITDA is -$14.05 million, with the most recent change of +$7.35 million (+34.35%) on June 30, 2025.
- Over the past year, ARQT quarterly EBITDA has increased by +$35.68 million (+71.75%).
- ARQT quarterly EBITDA is now -135.98% below its all-time high of -$5.95 million, reached on December 31, 2018.
Performance
ARQT Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$80.25M+$35.68M(+30.78%)Summary
- As of today, ARQT TTM EBITDA is -$80.25 million, with the most recent change of +$35.68 million (+30.78%) on June 30, 2025.
- Over the past year, ARQT TTM EBITDA has increased by +$98.04 million (+54.99%).
- ARQT TTM EBITDA is now -942.92% below its all-time high of -$7.70 million, reached on September 1, 2018.
Performance
ARQT TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
ARQT EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | +51.9% | +71.8% | +55.0% |
| 3Y3 Years | +46.8% | +78.6% | +68.7% |
| 5Y5 Years | -154.6% | +60.5% | +30.4% |
ARQT EBITDA Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +62.8% | -95.8% | +86.6% | at high | +74.5% |
| 5Y | 5-Year | -154.6% | +62.8% | -95.8% | +86.6% | at high | +74.5% |
| All-Time | All-Time | -2569.9% | +62.8% | -136.0% | +86.6% | -942.9% | +74.5% |
ARQT EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$14.05M(+34.3%) | -$80.25M(+30.8%) |
| Mar 2025 | - | -$21.40M(-198.3%) | -$115.93M(+7.8%) |
| Dec 2024 | -$109.63M(+51.9%) | -$7.17M(+80.9%) | -$125.80M(+29.9%) |
| Sep 2024 | - | -$37.63M(+24.3%) | -$179.41M(-0.6%) |
| Jun 2024 | - | -$49.73M(-59.1%) | -$178.29M(+8.5%) |
| Mar 2024 | - | -$31.26M(+48.6%) | -$194.85M(+18.6%) |
| Dec 2023 | -$227.79M(+22.7%) | -$60.78M(-66.5%) | -$239.49M(+2.9%) |
| Sep 2023 | - | -$36.52M(+44.9%) | -$246.70M(+21.6%) |
| Jun 2023 | - | -$66.29M(+12.7%) | -$314.70M(-0.2%) |
| Mar 2023 | - | -$75.90M(-11.6%) | -$314.00M(-4.5%) |
| Dec 2022 | -$294.87M(-43.2%) | -$68.00M(+34.9%) | -$300.50M(+1.0%) |
| Sep 2022 | - | -$104.51M(-59.3%) | -$303.58M(-18.6%) |
| Jun 2022 | - | -$65.59M(-5.1%) | -$255.95M(-10.2%) |
| Mar 2022 | - | -$62.40M(+12.2%) | -$232.26M(-12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$205.90M(-51.9%) | -$71.08M(-24.9%) | -$205.77M(-22.1%) |
| Sep 2021 | - | -$56.89M(-35.8%) | -$168.59M(-12.5%) |
| Jun 2021 | - | -$41.90M(-16.7%) | -$149.84M(-4.4%) |
| Mar 2021 | - | -$35.91M(-5.9%) | -$143.51M(-5.4%) |
| Dec 2020 | -$135.56M(-214.8%) | -$33.90M(+11.1%) | -$136.19M(-18.2%) |
| Sep 2020 | - | -$38.14M(-7.2%) | -$115.23M(-25.8%) |
| Jun 2020 | - | -$35.57M(-24.4%) | -$91.60M(-42.1%) |
| Mar 2020 | - | -$28.59M(-121.0%) | -$64.48M(-50.6%) |
| Dec 2019 | -$43.06M(-118.2%) | -$12.93M(+10.9%) | -$42.83M(-19.5%) |
| Sep 2019 | - | -$14.51M(-71.8%) | -$35.84M(-23.5%) |
| Jun 2019 | - | -$8.45M(-22.0%) | -$29.03M(-41.1%) |
| Mar 2019 | - | -$6.93M(-16.4%) | -$20.58M(-50.8%) |
| Dec 2018 | -$19.73M(-380.6%) | -$5.95M(+22.6%) | -$13.65M(-77.4%) |
| Sep 2018 | - | -$7.70M | -$7.70M |
| Dec 2017 | -$4.11M | - | - |
FAQ
- What is Arcutis Biotherapeutics, Inc. annual EBITDA?
- What is the all-time high annual EBITDA for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. annual EBITDA year-on-year change?
- What is Arcutis Biotherapeutics, Inc. quarterly EBITDA?
- What is the all-time high quarterly EBITDA for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
- What is Arcutis Biotherapeutics, Inc. TTM EBITDA?
- What is the all-time high TTM EBITDA for Arcutis Biotherapeutics, Inc.?
- What is Arcutis Biotherapeutics, Inc. TTM EBITDA year-on-year change?
What is Arcutis Biotherapeutics, Inc. annual EBITDA?
The current annual EBITDA of ARQT is -$109.63M
What is the all-time high annual EBITDA for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high annual EBITDA is -$4.11M
What is Arcutis Biotherapeutics, Inc. annual EBITDA year-on-year change?
Over the past year, ARQT annual EBITDA has changed by +$118.17M (+51.88%)
What is Arcutis Biotherapeutics, Inc. quarterly EBITDA?
The current quarterly EBITDA of ARQT is -$14.05M
What is the all-time high quarterly EBITDA for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high quarterly EBITDA is -$5.95M
What is Arcutis Biotherapeutics, Inc. quarterly EBITDA year-on-year change?
Over the past year, ARQT quarterly EBITDA has changed by +$35.68M (+71.75%)
What is Arcutis Biotherapeutics, Inc. TTM EBITDA?
The current TTM EBITDA of ARQT is -$80.25M
What is the all-time high TTM EBITDA for Arcutis Biotherapeutics, Inc.?
Arcutis Biotherapeutics, Inc. all-time high TTM EBITDA is -$7.70M
What is Arcutis Biotherapeutics, Inc. TTM EBITDA year-on-year change?
Over the past year, ARQT TTM EBITDA has changed by +$98.04M (+54.99%)